{"id":746442,"date":"2023-04-11T06:03:25","date_gmt":"2023-04-11T10:03:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/"},"modified":"2023-04-11T06:03:25","modified_gmt":"2023-04-11T10:03:25","slug":"q3-fy23-business-update-webinar-notification","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/","title":{"rendered":"Q3 FY23 Business Update Webinar Notification"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MELBOURNE, Australia, April  11, 2023  (GLOBE NEWSWIRE) &#8212; Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is pleased to advise it will provide a business update for the quarter ended 31 March 2023 (Q3 FY23).<\/p>\n<p align=\"justify\">Investors are invited to join a live webcast and Q&amp;A hosted by Immuron CEO Steven Lydeamore on <strong>Wednesday, 19 April 2023 at 11:00am (AEST)<\/strong>.<\/p>\n<p align=\"justify\">To register for the webinar, please click on this link:<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yfeMxLTfipS-DpUwDRAIfPHZBq0SBszPvoGkt1MEQjrbwD2PcF_FUUbNBFHM9aEhijtlCIlhvGraq30EgXu3ie0ly_J6RzolvQF0_Hkbou_IveKRP4SSHEKfQPZ8LNPYa792kgu8_36D3_Kx_flQ4hwxI7NvLjL1myXC2ktaV9IHIwztR2_lHTwiNI6on3skmxZQ_L9tURjor3hbcHcllQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/us02web.zoom.us\/webinar\/register\/WN_TpvaXZZ1QDG1FnZdXdtSGA<\/a>\n      <\/p>\n<p align=\"justify\">\n        <em>After registering, you will receive a confirmation email containing information about joining the webinar.<\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong>COMPANY CONTACT:<\/strong><\/p>\n<p>        <strong>Steven Lydeamore<\/strong><br \/>\n        <br \/>Chief Executive Officer<br \/>Ph:+61 (0)3 9824 5254<br \/>info@immuron.com<\/p>\n<p>\n        <strong>About Travelan<sup>\u00ae<br \/><\/sup><\/strong>Travelan\u00ae is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting travelers\u2019 diarrhea, a digestive tract disorder that is commonly caused by pathogenic bacteria and the toxins they produce. Travelan\u00ae is a highly purified tabletized preparation of hyper immune bovine antibodies and other factors, which when taken with meals bind to diarrhea-causing bacteria and prevent colonization and the pathology associated with travelers\u2019 diarrhea. In Australia, Travelan\u00ae is a listed medicine on the Australian Register for Therapeutic Goods (AUST L 106709) and is indicated to reduce the risk of Travelers\u2019 Diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. In Canada, Travelan<sup>\u00ae<\/sup> is a licensed natural health product (NPN 80046016) and is indicated to reduce the risk of Travelers\u2019 Diarrhea. In the U.S., Travelan\u00ae is sold as a dietary supplement for digestive tract protection.<\/p>\n<p>\n        <strong>About Travelers\u2019 diarrhea<br \/><\/strong>Travelers\u2019 diarrhea is a gastrointestinal infection with symptoms that include loose, watery (and occasionally bloody) stools, abdominal cramping, bloating, and fever, Enteropathogenic bacteria are responsible for most cases, with enterotoxigenic <em>Escherichia coli<\/em> (ETEC) playing a dominant causative role. Campylobacter spp. are also responsible for a significant proportion of cases. The more serious infections with Salmonella spp. the bacillary dysentery organisms belonging to Shigella spp. and Vibrio spp. (the causative agent of cholera) are often confused with travelers\u2019 diarrhea as they may be contracted while travelling and initial symptoms are often indistinguishable.<\/p>\n<p align=\"justify\">\n        <strong>About Immuron<\/strong><br \/>\n        <br \/>Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases.<\/p>\n<p align=\"justify\">For more information visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cviJzIzF9FbfW7-wjRwTJpglIfiq2GD6-NwGQCdOF0Rj1uwbC7l57FJ_eF8fTCBH1IPAVBIBeKqrRd0om06xLaQkS7NCzLBUjnGWNuPoJQ8=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.immuron.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YzUzNzUyZTEtMDliOC00MDUzLWE5NzEtMDUxZTdlMDUzZDhhLTEwMzE4NjU=\/tiny\/Immuron-Limited.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) &#8212; Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is pleased to advise it will provide a business update for the quarter ended 31 March 2023 (Q3 FY23). Investors are invited to join a live webcast and Q&amp;A hosted by Immuron CEO Steven Lydeamore on Wednesday, 19 April 2023 at 11:00am (AEST). To register for the webinar, please click on this link: https:\/\/us02web.zoom.us\/webinar\/register\/WN_TpvaXZZ1QDG1FnZdXdtSGA After registering, you will receive a confirmation email containing information about joining the webinar. COMPANY CONTACT: Steven Lydeamore Chief Executive OfficerPh:+61 (0)3 9824 5254info@immuron.com About Travelan\u00aeTravelan\u00ae is an &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Q3 FY23 Business Update Webinar Notification&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-746442","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Q3 FY23 Business Update Webinar Notification - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Q3 FY23 Business Update Webinar Notification - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) &#8212; Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is pleased to advise it will provide a business update for the quarter ended 31 March 2023 (Q3 FY23). Investors are invited to join a live webcast and Q&amp;A hosted by Immuron CEO Steven Lydeamore on Wednesday, 19 April 2023 at 11:00am (AEST). To register for the webinar, please click on this link: https:\/\/us02web.zoom.us\/webinar\/register\/WN_TpvaXZZ1QDG1FnZdXdtSGA After registering, you will receive a confirmation email containing information about joining the webinar. COMPANY CONTACT: Steven Lydeamore Chief Executive OfficerPh:+61 (0)3 9824 5254info@immuron.com About Travelan\u00aeTravelan\u00ae is an &hellip; Continue reading &quot;Q3 FY23 Business Update Webinar Notification&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-11T10:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Q3 FY23 Business Update Webinar Notification\",\"datePublished\":\"2023-04-11T10:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/\"},\"wordCount\":401,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/\",\"name\":\"Q3 FY23 Business Update Webinar Notification - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=\",\"datePublished\":\"2023-04-11T10:03:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/q3-fy23-business-update-webinar-notification\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Q3 FY23 Business Update Webinar Notification\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Q3 FY23 Business Update Webinar Notification - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/","og_locale":"en_US","og_type":"article","og_title":"Q3 FY23 Business Update Webinar Notification - Market Newsdesk","og_description":"MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) &#8212; Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is pleased to advise it will provide a business update for the quarter ended 31 March 2023 (Q3 FY23). Investors are invited to join a live webcast and Q&amp;A hosted by Immuron CEO Steven Lydeamore on Wednesday, 19 April 2023 at 11:00am (AEST). To register for the webinar, please click on this link: https:\/\/us02web.zoom.us\/webinar\/register\/WN_TpvaXZZ1QDG1FnZdXdtSGA After registering, you will receive a confirmation email containing information about joining the webinar. COMPANY CONTACT: Steven Lydeamore Chief Executive OfficerPh:+61 (0)3 9824 5254info@immuron.com About Travelan\u00aeTravelan\u00ae is an &hellip; Continue reading \"Q3 FY23 Business Update Webinar Notification\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-11T10:03:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Q3 FY23 Business Update Webinar Notification","datePublished":"2023-04-11T10:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/"},"wordCount":401,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/","name":"Q3 FY23 Business Update Webinar Notification - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=","datePublished":"2023-04-11T10:03:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgwNTI5NCM1NTE5MzE0IzIwMjAyOTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/q3-fy23-business-update-webinar-notification\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Q3 FY23 Business Update Webinar Notification"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=746442"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746442\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=746442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=746442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=746442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}